Other

Unrealized Gain (Loss) on Securities

Medtronic Unrealized Gain (Loss) on Securities decreased by 121.8% to -$12.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1100.0%, from -$1.00M to -$12.00M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2018
Last reportedQ3 2026Feb 24, 2026
Metric ID: cop_unrealized_gain_loss_on_securities

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$12.00M-$56.00M-$70.00M-$16.00M-$167.00M$107.00M-$19.00M-$19.00M$111.00M$76.00M$35.00M-$1.00M$19.00M$55.00M-$12.00M
QoQ Change-566.7%-25.0%+77.1%-943.8%+164.1%-117.8%+0.0%+684.2%-31.5%-53.9%-102.9%>999%+189.5%-121.8%
YoY Change-233.3%-198.2%+252.9%-18.8%+88.6%+3.7%+500.0%+284.2%-100.9%-75.0%+57.1%<-999%
Range-$167.00M$111.00M
CAGR+0.0%
Avg YoY Growth-45.0%
Median YoY Growth-7.5%

Frequently Asked Questions

What is Medtronic's unrealized gain (loss) on securities?
Medtronic (MDT) reported unrealized gain (loss) on securities of -$12.00M in Q4 2025.
How has Medtronic's unrealized gain (loss) on securities changed year-over-year?
Medtronic's unrealized gain (loss) on securities decreased by 1100.0% year-over-year, from -$1.00M to -$12.00M.